Submission of Scrutinizer Report for postal Ballot process
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Limited (BSE Scrip Code: 539561) declared results of a postal ballot conducted via remote e-voting from July 14 to August 12, 2025. Two special resolutions were put to shareholders: (1) Appointment of Mr. Bikram Kumar Mund (DIN: 06919513) as Non-Executive/Independent Director, which passed with 93.24% votes in favour (46.7 lakh in favour vs 3.39 lakh against), and (2) Appointment of Mr. Vijay Pal Singh Gulya (DIN: 01433784) as Non-Executive/Independent Director, which passed with 92.74% votes in favour (46.39 lakh in favour vs 3.63 lakh against). The scrutinizer was Ms. Riddhi Shah, Practicing Company Secretary. Out of 116,793 shareholders on the record date and 88.20 crore outstanding shares, only about 50 lakh votes (roughly 0.57% of outstanding shares) were polled, indicating very low shareholder participation. The promoter group did not cast any votes. Results were declared on August 13, 2025 by Whole Time Director Mr. Adarsh Munjal.
Both independent directors have been formally appointed to the board with overwhelming shareholder support, strengthening independent oversight. However, the extremely low voting turnout (under 1% of outstanding shares) and zero promoter participation may raise governance questions about shareholder engagement.